## [Innovative Drug Development in China](/index%2Ephp/webinars/innovative-drug-development-in-china)
Pharmaceuticals
Past Webinar
## **Innovative Drug Development in China**
**The webinar was successfully concluded on**
**March 27, 2025**
[Download Webinar](javascript:void(0))
#### **Topics Covered:**
We are delighted to see your interest in **Freyr’s Webinar Series**. The webinar on **"Innovative Drug Development in China"** was successfully concluded on **March 27, 2025**.
**Missed the live session?** No worries! Here is the archived session
**Key Takeaways from the Webinar:**
- Understanding China’s drug approval system, accelerated review pathways, and Regulatory communication strategies.
- Key strategies for drug development, clinical studies, and marketing authorization.
- Common challenges, industry benefits, and expert tips for navigating China’s pharmaceutical landscape.
As a continuous practice, Freyr continues to host informative webinars covering **Regulatory trends and best practices** in the Life Sciences industry. We would love to have you join our future sessions!
### ![]()
Shruti Dwivedi is an emerging Strategic Pharmaceutical Marketer with experience in International B2B Marketing Management. As the Team Lead for Marketing Strategy,she supports Regulatory Marketing Initiatives across the Asia Pacific and Latin America regions by contributing to Brand Management and Global Marketing Campaigns.
### ![]()
Jane Zhang has over seventeen (17+) years of experience in new drug R&D and more than twenty (20+) years of experience in Regulatory Affairs (RA). She possesses a deep understanding of NMPA and global regulations, including FDA, EU, and ICH. Her strong scientific background, extensive knowledge, and previous role as a CDE reviewer contribute to her comprehensive understanding and interpretation of these regulations.
## Host
### Shruti Dwivedi
Team Lead, MPR Marketing Strategy
## Presenter
### Jane Zhang
Sr. Director Regulatory Affairs, Freyr China